Roche

Mentioned in 12 analyzed podcast episodes across 10 shows

Mentioned On

Pharma and BioTech Daily Networth and Chill with Your Rich BFF The Top Line ZOE Science & Nutrition Vital Dawn Behind the Bastards The a16z Show This Week in Virology Something You Should Know Dwarkesh Podcast

Episode Mentions

Pharma and BioTech Daily · Jul 16, 2026

Veradermics' $2B Hair Loss Market Move with Oral Minoxidil | Pharma and Biotech Daily

“Exploring multifaceted Alzheimer's approach targeting both amyloid and tau proteins in phase 3 programs”

Oral Minoxidil for Female Pattern Hair LossPatent Cliff Management in PharmaceuticalsAI-Driven Drug Discovery Partnerships

View Analysis

Networth and Chill with Your Rich BFF · Jul 15, 2026

How GLP-1s Are Reshaping the Economy and Who's Really Paying for It

“Implied competitor in GLP-1 market developing alternative formulations and delivery methods”

GLP-1 Drugs and Weight Loss MedicationsWeight Discrimination in the WorkplaceHealth Insurance Coverage and Affordability

View Analysis

The Top Line · Jul 10, 2026

A $10B deal, China trial scrutiny and highlights from ADA 2026

“Developing late-stage obesity candidate; executives engaged at ADA conference on metabolic health strategy”

Vertex Crinetics acquisition and rare endocrine disease expansionClinical trial regulation and China data integrity scrutinyGLP-1 agonist efficacy and weight loss outcomes

View Analysis

Pharma and BioTech Daily · May 13, 2026

Pfizer's $85M Breast Cancer Deal & FDA Shakeup | Pharma and Biotech Daily

“Achieved European approval for second Alzheimer's disease diagnostic test in collaboration with Eli Lilly”

FDA Leadership Transition and Regulatory StrategyPrecision Oncology and Targeted Breast Cancer TherapiesBiosimilar Competition and Market Erosion

View Analysis

ZOE Science & Nutrition · Apr 30, 2026

Should you take Ozempic? The 5 things you need to know before starting GLP-1 drugs | Dr Ania Jastreboff

“Mentioned in context of historical drug safety issues (Vioxx) as cautionary example of miracle drugs”

GLP-1 Receptor Agonists Mechanism of ActionMulti-Receptor Drug Development (GLP-1, GIP, Glucagon, Amylin)Body Fat Set Point and Appetite Regulation

View Analysis

Pharma and BioTech Daily · Apr 24, 2026

Regeneron Gene Therapy Approved by FDA: A Game-Changer! | Pharma and Biotech Daily

“Recent earnings report reveals several key drugs underperformed expectations amid currency fluctuations and market competition”

Gene Therapy Regulation and FDA Approval PathwaysHearing Loss Treatment InnovationGLP-1 Receptor Agonists for Type 2 Diabetes

View Analysis

Vital Dawn · Apr 23, 2026

Vital Dawn Podcast for Thursday April 23

“European healthcare company trading up on earnings report”

Semiconductor Earnings and AI ExposureSoftware Sector Weakness and Margin PressureTesla Q1 Earnings and CapEx Guidance

View Analysis

Behind the Bastards · Mar 3, 2026

Part One: Dr. Sleep: The Australian Psychiatrist Who Made People Sleep Themselves To Death

“Pharmaceutical manufacturer whose barbiturates were exclusively used by early DST pioneer Jacob Kleisse in his treatment protocols”

Deep Sleep Therapy (DST) - medical history and dangersPsychiatric treatment ethics and informed consent in mid-20th centuryFinancial incentive structures in healthcare and overtreatment

View Analysis

The a16z Show · Feb 16, 2026

Novartis CEO Vasant Narasimhan on Transforming a 250-Year-Old Company

“Novartis sold its stake in Roche as part of portfolio simplification strategy”

Corporate transformation and spin-offsCell and gene therapy platformsRNA therapeutics and siRNA technology

View Analysis

This Week in Virology · Jan 31, 2026

TWiV 1292: Clinical update with Dr. Daniel Griffin

“Manufacturer of Zofluza (baloxavir marboxil), single-dose influenza antiviral discussed as alternative to Tamiflu”

WHO Withdrawal and Global Health GovernanceVaccine Hesitancy and Immunization PolicyMeasles Resurgence and Elimination Status

View Analysis

Something You Should Know · Jan 5, 2026

How Ozempic and Similar Weight Loss Drugs Really Work & The Story of Money

“Swiss pharmaceutical company developing a GLP-1 drug franchise to compete in weight loss medication market”

GLP-1 Receptor Agonists and Weight Loss MechanismsMental Imagery and Skill AcquisitionOzempic and Semaglutide Side Effects

View Analysis

Dwarkesh Podcast · Aug 21, 2025

Evolution designed us to die fast; we can change that — Jacob Kimmel

“Pharma company with significant internal R&D in perturb-seq technology and cellular reprogramming led by Viola Gev”

Evolutionary constraints on human lifespan and agingEpigenetic reprogramming and cell age reversalTranscription factors as therapeutic targets

View Analysis